We are live on ! Find out more
ACM

Ayrshire Capital Management Portfolio holdings

AUM $214M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+20.58%
3 Year Est. Return
+78.45%
5 Year Est. Return
+99.59%
10 Year Est. Return
AUM
$173M
AUM Growth
+$18.6M
Cap. Flow
+$567K
Cap. Flow %
0.33%
Top 10 Hldgs %
39.73%
Holding
51
New
4
Increased
31
Reduced
10
Closed
3

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$2.88M
2
PG icon
Procter & Gamble
PG
+$845K
3
VLTO icon
Veralto
VLTO
+$643K
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$343K
5
WFC icon
Wells Fargo
WFC
+$324K

Top Sells

Rank Stock Value
1
DOV icon
Dover
DOV
+$2.91M
2
MRNA icon
Moderna
MRNA
+$2.05M
3
DHR icon
Danaher
DHR
+$556K
4
CL icon
Colgate-Palmolive
CL
+$377K
5
GBDC icon
Golub Capital BDC
GBDC
+$215K

Sector Composition

Rank Sector Weight
1 Technology 31.24%
2 Healthcare 18.08%
3 Financials 16.29%
4 Consumer Staples 12.84%
5 Consumer Discretionary 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BUD icon
26
AB InBev
BUD
$153B
$3.81M 2.2%
58,912
+2,236
+4% +$132K
LLY icon
27
Eli Lilly
LLY
$1.11T
$3.62M 2.09%
6,205
+269
+5% +$157K
ETN icon
28
Eaton
ETN
$161B
$3.14M 1.81%
+13,040
New +$2.88M
NKE icon
29
Nike
NKE
$59.7B
$2.83M 1.63%
26,087
+420
+2% +$45.1K
CL icon
30
Colgate-Palmolive
CL
$71.5B
$2.54M 1.47%
31,913
-5,020
-14% -$377K
SPY icon
31
State Street SPDR S&P 500 ETF Trust
SPY
$805B
$1.47M 0.85%
3,087
+69
+2% +$30.7K
QCOM icon
32
Qualcomm
QCOM
$169B
$1.32M 0.76%
9,094
-85
-0.9% -$10.5K
CRM icon
33
Salesforce
CRM
$168B
$1.25M 0.72%
4,748
+9
+0.2% +$2.04K
ARCC icon
34
Ares Capital
ARCC
$14.2B
$1.18M 0.68%
58,943
+1,796
+3% +$35K
AMT icon
35
American Tower
AMT
$81.9B
$1.04M 0.6%
4,821
-537
-10% -$101K
AMGN icon
36
Amgen
AMGN
$235B
$1.02M 0.59%
3,546
+62
+2% +$16.9K
VLTO icon
37
Veralto
VLTO
$24.2B
$708K 0.41%
+8,608
New +$643K
COP icon
38
ConocoPhillips
COP
$162B
$648K 0.37%
5,581
+59
+1% +$6.9K
DGRO icon
39
iShares Core Dividend Growth ETF
DGRO
$43.5B
$529K 0.31%
9,837
+199
+2% +$10.1K
SPGI icon
40
S&P Global
SPGI
$127B
$441K 0.25%
1,000
-4
-0.4% -$1.58K
GILD icon
41
Gilead Sciences
GILD
$178B
$437K 0.25%
5,400
MDY icon
42
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.8B
$411K 0.24%
810
+1
+0.1% +$464
WFC icon
43
Wells Fargo
WFC
$253B
$370K 0.21%
+7,510
New +$324K
VOO icon
44
Vanguard S&P 500 ETF
VOO
$1.02T
$366K 0.21%
+837
New +$343K
BRK.B icon
45
Berkshire Hathaway Class B
BRK.B
$1.06T
$323K 0.19%
905
+20
+2% +$7.02K
NVDA icon
46
NVIDIA
NVDA
$5.25T
$313K 0.18%
6,330
+840
+15% +$38.9K
SBT
47
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$75.6K 0.04%
13,102
DOV icon
48
Dover
DOV
$26.9B
-20,873
Closed -$2.91M
GBDC icon
49
Golub Capital BDC
GBDC
$3.43B
-14,634
Closed -$215K
MRNA icon
50
Moderna
MRNA
$53.2B
-19,855
Closed -$2.05M

Similar funds

Ayrshire Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Ayrshire Capital Management held 51 positions worth $173M, up 12% from $155M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Ayrshire Capital Management's Q4 2023 filing shows 4 new, 31 increased, 10 reduced and 3 closed positions. Its largest new stake was Eaton: 13,040 shares worth $3.14M. The largest sale was Dover, an estimated $2.91M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Ayrshire Capital Management's largest Q4 2023 buy was Eaton: 13,040 shares worth $3.14M.
  • Ayrshire Capital Management added most to Procter & Gamble in Q4 2023, an estimated $845K increase.
  • Ayrshire Capital Management's biggest Q4 2023 reduction was Danaher, cutting an estimated $556K.
  • Ayrshire Capital Management fully exited Dover in Q4 2023, selling an estimated $2.91M.
  • Ayrshire Capital Management's ten largest holdings make up 40% of its $173M portfolio in Q4 2023.
  • Ayrshire Capital Management opened 4 new positions and closed 3 in Q4 2023.
  • Ayrshire Capital Management's portfolio value rose 12% quarter-over-quarter to $173M.

Based on Ayrshire Capital Management's 13F filing for Q4 2023, filed 9 Jan 2024.